Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Soki Kashima"'
Autor:
Kazuyuki Numakura, Yuya Sekine, Shingo Hatakeyama, Yumina Muto, Ryuta Sobu, Mizuki Kobayashi, Hajime Sasagawa, Soki Kashima, Ryohei Yamamto, Taketoshi Nara, Hideo Akashi, Ryuji Tabata, Satoshi Sato, Mitsuru Saito, Shintaro Narita, Chikara Ohyama, Tomonori Habuchi
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16837-16845 (2023)
Abstract Background Nivolumab plus ipilimumab (NIVO+IPI) is the first‐line treatment for patients with metastatic renal cell carcinoma (mRCC). Approximately 40% of patients achieve a durable response; however, 20% develop primary resistant disease
Externí odkaz:
https://doaj.org/article/071fb040d8e54cf6807375d01f877ff2
Autor:
Keisuke Okubo, Shintaro Narita, Atsushi Koizumi, Yoshiko Takahashi, Ryuichiro Sagehashi, Kanami Mori, Ryuta Sobu, Hiromi Sato, Soki Kashima, Mizuki Kobayashi, Ryohei Yamamoto, Taketoshi Nara, Kazuyuki Numakura, Mitsuru Saito, Hiroshi Nanjyo, Tomonori Habuchi
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 621-627 (2023)
A 66-year-old male was diagnosed with cT4N0M1b small-cell neuroendocrine carcinoma of the prostate. Four months after the administration of combined androgen blockade, multiple novel metastatic regions in the lung and liver and progression of bone me
Externí odkaz:
https://doaj.org/article/f2d15b40e88647d68f625a2c33fd5ce0
Autor:
Mario Sznol, Harriet Kluger, Michael Hurwitz, Adebowale Adeniran, Peter Humphrey, David Braun, Lena Wirth, Soki Kashima, Hanna Soulati, Katrine Madsen, Katherine Sadak, Patrick Kenney
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ae26b4bac3ae4c5685120cdd4801bbc5
Autor:
Kazuyuki Numakura, Mizuki Kobayashi, Atsushi Koizumi, Soki Kashima, Ryohei Yamamoto, Taketoshi Nara, Mitsuru Saito, Shintaro Narita, Takamitsu Inoue, Tomonori Habuchi
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-6 (2022)
Abstract Introduction Warm ischemia time (WIT) is a primary concern for robot-assisted laparoscopic partial nephrectomy (RALPN) patients because longer WIT is significantly associated with postoperative deteriorating kidney function. Tumor complexity
Externí odkaz:
https://doaj.org/article/4ba267f4f7a547afa24681e228ddc33f
Autor:
Mingguo Huang, Atsushi Koizumi, Shintaro Narita, Hiroki Nakanishi, Hiromi Sato, Soki Kashima, Taketoshi Nara, Sohei Kanda, Kazuyuki Numakura, Mitsuru Saito, Shigeru Satoh, Hiroshi Nanjo, Takehiko Sasaki, Tomonori Habuchi
Publikováno v:
MedComm, Vol 2, Iss 4, Pp 756-764 (2021)
Abstract The metabolic reprogramming of phospholipids may affect intracellular signal transduction pathways. A high‐fat diet (HFD) is attributed to prostate cancer (PCa) progression, but the expression pattern and role of phospholipids in HFD‐med
Externí odkaz:
https://doaj.org/article/ff5e18e81930498c98ef5d04af93d24f
Autor:
Naoko Nose, Suguru Nogami, Kazuhiro Koshino, Xinyu Chen, Rudolf A. Werner, Soki Kashima, Steven P. Rowe, Constantin Lapa, Kazuki Fukuchi, Takahiro Higuchi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Stem cell therapy holds great promise for tissue regeneration and cancer treatment, although its efficacy is still inconclusive and requires further understanding and optimization of the procedures. Non-invasive cell tracking can provide an
Externí odkaz:
https://doaj.org/article/9212afd2f67542e299355bc54cce9b67
Autor:
Masashi Takeda, Soki Kashima, Yasushi Fuchigami, Takayuki Yoshino, Tatsuki R. Kataoka, Toshinari Yamasaki, Hiroshi Kagamu, Takashi Kobayashi, Shusuke Akamatsu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Renal cell carcinoma unclassified with medullary phenotype (RCCU-MP) is an extremely rare variant of kidney cancer with poor prognosis. Recently, immune checkpoint inhibitors (ICIs) have been the mainstay of treatment for advanced clear cell renal ce
Externí odkaz:
https://doaj.org/article/06d5c2f350a84d53b92fbb5e955f14da
Autor:
Takuya Maeda, Seiji Nagano, Soki Kashima, Koji Terada, Yasutoshi Agata, Hiroshi Ichise, Manami Ohtaka, Mahito Nakanishi, Fumihiro Fujiki, Haruo Sugiyama, Toshio Kitawaki, Norimitsu Kadowaki, Akifumi Takaori-Kondo, Kyoko Masuda, Hiroshi Kawamoto
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 19, Iss , Pp 250-260 (2020)
In the current adoptive T cell therapy, T cells from a patient are given back to that patient after ex vivo activation, expansion, or genetic manipulation. However, such strategy depends on the quality of the patient’s T cells, sometimes leading to
Externí odkaz:
https://doaj.org/article/e94f6375e43049b79591e27e60345c7a
Autor:
Hiroki Hagimoto, Soki Kashima, Kazuki Doi, Shintaro Nakayama, Takanori Sano, Satoshi Imai, Tomihiko Yasufuku, Mototsugu Muramaki, Yuji Yamada
Publikováno v:
IJU Case Reports, Vol 3, Iss 6, Pp 287-290 (2020)
Introduction Nivolumab is effective for advanced renal cell carcinoma; however, reports are limited wherein nivolumab is combined with sequential therapy of angiogenesis inhibitors and metastasectomy. Case presentation A 65‐year‐old man was diagn
Externí odkaz:
https://doaj.org/article/fb56cc9cf4c1481ba8890b0ecbd0898a
Autor:
Seiji Nagano, Takuya Maeda, Hiroshi Ichise, Soki Kashima, Manami Ohtaka, Mahito Nakanishi, Toshio Kitawaki, Norimitsu Kadowaki, Akifumi Takaori-Kondo, Kyoko Masuda, Hiroshi Kawamoto
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 16, Iss , Pp 126-135 (2020)
Current adoptive T cell therapies conducted in an autologous setting are costly, time-consuming, and depend on the quality of the patient’s T cells, and thus it would be highly beneficial to develop an allogeneic strategy. To this aim, we have deve
Externí odkaz:
https://doaj.org/article/1149dc76f1b64229944bceb0a2222a6e